Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Therapeutic Advances.
It is demonstrated that mitochondrial impairment precedes classical neuropathological hallmarks, thereby positioning mitochondrial dysfunction as a primary driver rather than a secondary consequence of neurodegeneration, and critically evaluates the translational landscape of mitochondria-targeted interventions.